The price of a drug should be based on its therapeutic benefits – not just what the market will bear

To stretch or not to stretch: What you need to know about exercise warm-ups
14 January 2021
WHO deplores 95% of vaccine doses limited to 10 countries
14 January 2021

The price of a drug should be based on its therapeutic benefits – not just what the market will bear

The U.S. pharmaceutical industry has innovated in response to the pandemic, providing not only vaccines but also therapies to treat people with COVID-19. But an outdated law designed to spur development of lifesaving drugs risks making new treatments—for COVID-19 as well as other diseases—unaffordable for many Americans.

Comments are closed.